These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7665213)
21. Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment. McLachlan RI; Robertson DM; Pruysers E; Ugoni A; Matsumoto AM; Anawalt BD; Bremner WJ; Meriggiola C J Clin Endocrinol Metab; 2004 Jan; 89(1):142-9. PubMed ID: 14715841 [TBL] [Abstract][Full Text] [Related]
22. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone. Anderson RA; Wallace AM; Wu FC J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548 [TBL] [Abstract][Full Text] [Related]
23. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate. Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948 [TBL] [Abstract][Full Text] [Related]
24. Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception. Kamischke A; Plöger D; Venherm S; von Eckardstein S; von Eckardstein A; Nieschlag E Clin Endocrinol (Oxf); 2000 Jul; 53(1):43-52. PubMed ID: 10931079 [TBL] [Abstract][Full Text] [Related]
25. Reversible azoospermia induced by an androgen-progestin combination regimen in Indonesian men. Pangkahila W Int J Androl; 1991 Aug; 14(4):248-56. PubMed ID: 1831798 [TBL] [Abstract][Full Text] [Related]
26. The influence of pharmaceutical compounds on male fertility. Neumann F; Diallo FA; Hasan SH; Schenck B; Traore I Andrologia; 1976; 8(3):203-35. PubMed ID: 793446 [TBL] [Abstract][Full Text] [Related]
27. Suppression of spermatogenesis by testosterone enanthate in Thai men. Aribarg A; Sukcharoen N; Chanprasit Y; Ngeamvijawat J; Kriangsinyos R J Med Assoc Thai; 1996 Oct; 79(10):624-9. PubMed ID: 8996996 [TBL] [Abstract][Full Text] [Related]
28. Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men. Wang C; Wang XH; Nelson AL; Lee KK; Cui YG; Tong JS; Berman N; Lumbreras L; Leung A; Hull L; Desai S; Swerdloff RS J Clin Endocrinol Metab; 2006 Feb; 91(2):460-70. PubMed ID: 16278260 [TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation of long-term treatment with levo-norgestrel and testosterone enanthate in normal men. Foegh M; Nicol K; Petersen IB; Schou G Contraception; 1980 Jun; 21(6):631-40. PubMed ID: 6775869 [TBL] [Abstract][Full Text] [Related]
30. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism. Wu FC; Balasubramanian R; Mulders TM; Coelingh-Bennink HJ J Clin Endocrinol Metab; 1999 Jan; 84(1):112-22. PubMed ID: 9920070 [TBL] [Abstract][Full Text] [Related]
31. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens. Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047 [TBL] [Abstract][Full Text] [Related]
32. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: effects of long term treatment with GnRH agonist infusion and androgen. Bhasin S; Yuan QX; Steiner BS; Swerdloff RS J Clin Endocrinol Metab; 1987 Sep; 65(3):568-74. PubMed ID: 3114307 [TBL] [Abstract][Full Text] [Related]
33. Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression. Anawalt BD; Herbst KL; Matsumoto AM; Mulders TM; Coelingh-Bennink HJ; Bremner WJ Fertil Steril; 2000 Oct; 74(4):707-14. PubMed ID: 11020511 [TBL] [Abstract][Full Text] [Related]
34. Levonorgestrel enhances spermatogenesis suppression by testosterone with greater alteration in testicular gene expression in men. Lue Y; Wang C; Cui Y; Wang X; Sha J; Zhou Z; Xu J; Wang C; Hikim AP; Swerdloff RS Biol Reprod; 2009 Mar; 80(3):484-92. PubMed ID: 19074003 [TBL] [Abstract][Full Text] [Related]
35. transient scrotal hyperthermia and levonorgestrel enhance testosterone-induced spermatogenesis suppression in men through increased germ cell apoptosis. Wang C; Cui YG; Wang XH; Jia Y; Sinha Hikim A; Lue YH; Tong JS; Qian LX; Sha JH; Zhou ZM; Hull L; Leung A; Swerdloff RS J Clin Endocrinol Metab; 2007 Aug; 92(8):3292-304. PubMed ID: 17504903 [TBL] [Abstract][Full Text] [Related]
36. Progress in research into new methods of fertility regulation for men. Prog Hum Reprod Res; 1995; (33):2. PubMed ID: 12289975 [TBL] [Abstract][Full Text] [Related]
37. Male contraceptive research steps back into spotlight. Bonn D Lancet; 1999 Jan; 353(9149):302. PubMed ID: 9929036 [TBL] [Abstract][Full Text] [Related]
38. Suppression of testicular and epididymal functions in a non-human primate (bonnet monkey) by combined administration of a gonadotropin-releasing hormone antagonist and testosterone buciclate. Rajalakshmi M; Kumar PK; Kinger S; Pal PC; Pruthi JS; Bajaj JS Contraception; 1995 Dec; 52(6):381-8. PubMed ID: 8749603 [TBL] [Abstract][Full Text] [Related]
39. Testosterone/progestin regimens: a realistic option for male contraception? Amory JK Curr Opin Investig Drugs; 2004 Oct; 5(10):1025-30. PubMed ID: 15535423 [TBL] [Abstract][Full Text] [Related]
40. Predictors for partial suppression of spermatogenesis of hormonal male contraception. Li JW; Gu YQ Asian J Androl; 2008 Sep; 10(5):723-30. PubMed ID: 18645675 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]